Search
인용 및 참조 문헌 (17)
Gibco™
StemPro™-34 SFM (1X)
StemPro-34 SFM is a serum-free medium specifically formulated to support the development of human hematopoietic cells in culture, including HSC자세히 알아보기
| 카탈로그 번호 | 수량 |
|---|---|
| 10639011 | 500 mL |
카탈로그 번호 10639011
제품 가격(KRW)
594,000
キャンペーン価格
Ends: 31-Dec-2025
659,000할인액 65,000 (10%)
Each
수량:
500 mL
제품 가격(KRW)
594,000
キャンペーン価格
Ends: 31-Dec-2025
659,000할인액 65,000 (10%)
Each
StemPro-34 SFM is a serum-free medium specifically formulated to support the development of human hematopoietic cells in culture, including HSC and progenitor cells isolated from bone marrow, neonatal cord blood, and peripheral blood. It is a flexible cell culture medium that can be used for a wide variety of applications and workflows, including differentiation, HSC expansion, gene editing of HSCs. and iPSC reprogramming.
For human ex vivo tissue and cell culture processing applications. CAUTION: When used as a medical device, Federal Law restricts this device to sale by or on the order of a physician.
사양
세포 유형Hematopoietic Stem Cell, Hematopoietic Cell, Bone Marrow
엔도톡신 수준≤ 10 EU/mL
제품라인StemPro
제품 유형Stem Cell Serum Free Media (SFM)
수량500 mL
종Human
분류Serum-free
Culture TypeStationary Suspension Culture
형태Liquid
Serum LevelSerum-free
첨가제 포함Phenol Red
첨가제 없음No Glutamine
Unit SizeEach
구성 및 보관
• 500 ml StemPro™-34 Serum Free Medium (store at 2°C to 8°C in the dark)
• 13 ml StemPro™-34 Nutrient Supplement (store at -5°C to -20°C in the dark)
Store the complete medium at 2°C to 8°C in the dark.
• 13 ml StemPro™-34 Nutrient Supplement (store at -5°C to -20°C in the dark)
Store the complete medium at 2°C to 8°C in the dark.
인용 및 참조 문헌 (17)
인용 및 참조 문헌
Abstract
Functional profiling of single CRISPR/Cas9-edited human long-term hematopoietic stem cells.
Journal:Nature communications
PubMed ID:31628330
In the human hematopoietic system, rare self-renewing multipotent long-term hematopoietic stem cells (LT-HSCs) are responsible for the lifelong production of mature blood cells and are the rational target for clinical regenerative therapies. However, the heterogeneity in the hematopoietic stem cell compartment and variable outcomes of CRISPR/Cas9 editing make functional interrogation
Ex vivo expanded human cord blood-derived hematopoietic progenitor cells induce lung growth and alveolarization in injured newborn lungs.
Journal:Respiratory research
PubMed ID:23522153
BACKGROUND: We investigated the capacity of expanded cord blood-derived CD34+ hematopoietic progenitor cells to undergo respiratory epithelial differentiation ex vivo, and to engraft and attenuate alveolar disruption in injured newborn murine lungs in vivo. METHODS: Respiratory epithelial differentiation was studied in CD34+ cells expanded in the presence of growth factors
Human pluripotent stem cells differentiated in fully defined medium generate hematopoietic CD34- and CD34+ progenitors with distinct characteristics.
Journal:PloS one
PubMed ID:21364915
BACKGROUND: Differentiation of pluripotent stem cells in vitro provides a powerful means to investigate early developmental fates, including hematopoiesis. In particular, the use of a fully defined medium (FDM) would avoid biases induced by unidentified factors contained in serum, and would also allow key molecular mediators involved in such a
Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures.
Journal:Blood
PubMed ID:17148580
The onset of hematopoiesis in the mouse embryo and in the embryonic stem (ES) cell differentiation model is defined by the emergence of the hemangioblast, a progenitor with both hematopoietic and vascular potential. While there is evidence for the existence of a hemangioblast in the mouse, it is unclear if
Differentiation of Human-Induced Pluripotent Stem Cells to Macrophages for Disease Modeling and Functional Genomics.
Journal:Current protocols in stem cell biology
PubMed ID:30537374
Macrophages play important roles in many diseases. We describe a protocol and the associated resources for the differentiation of human induced pluripotent stem cell-derived macrophages (IPSDM) and their applications in understanding human macrophage physiology and relevant diseases. The protocol uses an embryoid bodyâbased approach with a combination of serum-free condition